Federal Register / Vol. 75, No. 212 / Wednesday, November 3, 2010 / Notices 67751 

Toxicology Testing Service, Inc., 5426 

N.W. 79th Ave., Miami, FL 33166, 305– 

593–2260. 

US Army Forensic Toxicology Drug 

Testing Laboratory, 2490 Wilson St., 

Fort George G. Meade, MD 20755–5235, 

301–677–7085. 

*The Standards Council of Canada 

(SCC) voted to end its Laboratory 

Accreditation Program for Substance 

Abuse (LAPSA) effective May 12, 1998. 

Laboratories certified through that 

program were accredited to conduct 

forensic urine drug testing as required 

by U.S. Department of Transportation 

(DOT) regulations. As of that date, the 

certification of those accredited 

Canadian laboratories will continue 

under DOT authority. The responsibility 

for conducting quarterly performance 

testing plus periodic on-site inspections 

of those LAPSA-accredited laboratories 

was transferred to the U.S. HHS, with 

the HHS’ NLCP contractor continuing to 

have an active role in the performance 

testing and laboratory inspection 

processes. Other Canadian laboratories 

wishing to be considered for the NLCP 

may apply directly to the NLCP 

contractor just as U.S. laboratories do. 

Upon finding a Canadian laboratory to 

be qualified, HHS will recommend that 

DOT certify the laboratory (Federal 

Register, July 16, 1996) as meeting the 

minimum standards of the Mandatory 

Guidelines published in the Federal 

Register on April 30, 2010 (75 FR 

22809). After receiving DOT 

certification, the laboratory will be 

included in the monthly list of HHScertified laboratories and participate in 

the NLCP certification maintenance 

program. 

Dated: October 28, 2010. 

Elaine Parry, 

Director, Office of Management, Technology, 

and Operations, SAMHSA. 

[FR Doc. 2010–27728 Filed 11–2–10; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–5055–N] 

Medicare Program: Community-Based 

Care Transitions Program (CCTP) 

Meeting 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), HHS. 

ACTION: Notice of meeting. 

SUMMARY: This notice announces a 

public conference hosted by CMS. This 

conference will provide a forum for 

community-based organizations, 

hospitals, Quality Improvement 

Organizations, Administration on Aging 

grantees, and other healthcare providers 

to receive useful guidance and ask 

questions about the upcoming 

Community-based Care Transitions 

Program. The meeting is open to the 

public, but attendance is limited to 

space and Webinar lines available. 

DATES: Meeting Date: Friday, December 

3, 2010, from 8 a.m. to 4 p.m., eastern 

standard time (e.s.t.). 

Deadline for Webinar or Web-based 

Registration: Thursday, December 2, 

2010, 8 a.m., e.s.t. 

Deadline for Meeting Registration: 

Friday, November 19, 2010, 4 p.m., e.s.t. 

Limited walk-in registration may be 

available the evening prior to the 

conference and the morning of the 

conference as space permits. 

ADDRESSES: Meeting Location: Marriott 

Waterfront Hotel, 700 Aliceanna Street, 

Baltimore, MD 21202. 

Registration: The meeting is open to 

the public, but attendance is limited to 

space and Webinar lines available. A 

link to the agenda and registration 

information will be posted on the CMS 

Care Transitions Web site at http:// 

www.cms.gov/DemoProjectsEvalRpts/ 

MD/ 

itemdetail.asp?itemID=CMS1239313 as 

soon as it is available. Persons wishing 

to attend this meeting in person or via 

Webinar are encouraged to register in 

advance. 

Special Accommodations: Individuals 

who require special accommodations 

should send an e-mail request to 

CareTransitions@cms.hhs.gov or via 

regular mail to the address specified in 

the FOR FURTHER INFORMATION CONTACT

section of this notice. Presentation 

materials will be posted on the CMS 

Care Transitions Web site prior to the 

meeting. 

FOR FURTHER INFORMATION CONTACT: 

Juliana Tiongson, Social Science 

Research Analyst, Centers for Medicare 

& Medicaid Services, 7500 Security 

Boulevard, Baltimore, MD 21244–1850, 

Mail Stop C4–14–15, telephone 410– 

786–0342 or e-mail 

Juliana.Tiongson@cms.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background 

Community-based organizations 

(CBOs) are defined in the statute as 

community-based organizations that 

provide care transition services across a 

continuum of care through 

arrangements with subsection (d) 

hospitals (as defined in section 

1886(d)(1)(B) of the Social Security Act) 

and whose governing body includes 

sufficient representation of multiple 

health care stakeholders, including 

consumers. Experts in the field will 

present evidence-based care transition 

models, and lessons learned from 

participation in the Quality 

Improvement Organizations’ (QIOs) 9th 

scope of work care transitions subnational theme and related initiatives. 

Healthcare leaders will present broader, 

hospital-based interventions to reduce 

readmissions, as well as the positive 

financial implications of successfully 

reducing readmissions. This conference 

will also provide an overview of the 

Community-based Care Transitions 

Program (CCTP) and provide the 

opportunity for hospitals to connect 

with CBOs in their communities. Once 

a solicitation for the CCTP is published, 

proposals will be accepted on a rolling 

quarterly basis beginning in early 2011. 

II. Meeting Agenda 

The agenda for the December 3, 2010 

meeting will include the following topic 

areas: 

• Overview of the CCTP under 

section 3026 of the Affordable Care Act. 

• The Business Case for Improving 

Care Transitions. 

• Building Community Support and 

Root Cause Analysis. 

• Overview of Care Transition 

Interventions. 

• Implementation of Care Transition 

Interventions—Successes and 

Challenges. 

Authority: Section 3026 of the Affordable 

Care Act 

Dated: October 21, 2010. 

Donald M. Berwick, 

Administrator, Centers for Medicare & 

Medicaid Services. 

[FR Doc. 2010–27789 Filed 10–29–10; 4:15 pm] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Center for Scientific 

Review Special Emphasis Panel, 

November 18, 2010, 2 p.m. to November 

18, 2010, 4 p.m., National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, 

MD 20892 which was published in the 

Federal Register on October 25, 2010, 

75 FR 65498–65499. 

The meeting title has been changed to 

‘‘RFA Panel: Translational Research in 

Pediatric and Obstetric Pharmacology’’. 

The meeting is closed to the public. 


jlentini on DSKJ8SOYB1PROD with NOTICES
67752 Federal Register / Vol. 75, No. 212 / Wednesday, November 3, 2010 / Notices 

Dated: October 28, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–27769 Filed 11–2–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Small 

Business: Devices and Detection Systems. 

Date: November 17–18, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Allerton Hotel, 701 North 

Michigan Avenue, Chicago, IL 60611. 

Contact Person: Ross D Shonat, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6172, 

MSC 7892, Bethesda, MD 20892. 301–435– 

2786. ross.shonat@nih.hhs.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflicts: Voice and Speech. 

Date: November 22, 2010. 

Time: 1 p.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call.) 

Contact Person: Weijia Ni, PhD, Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 3184, MSC 7848, Bethesda, MD 

20892. (301) 237–9918. niw@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: October 28, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–27743 Filed 11–2–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES (HHS) 

Centers for Disease Control and 

Prevention (CDC) 

Request for Nominations of 

Candidates To Serve on the 

Interagency Committee on Smoking 

and Health, (ICSH) 

The ICSH is soliciting nominations for 

consideration of membership on the 

committee. This committee provides 

advice and guidance to the Secretary, 

HHS, and the Director, CDC regarding 

(a) coordination of all research and 

education programs and other activities 

within the Department and with other 

federal, State, local and private agencies 

and (b) establishment and maintenance 

of liaison with appropriate private 

entities, federal agencies, and State and 

local public health agencies with 

respect to smoking and health activities. 

Nominations are being sought for 

individuals who have expertise and 

qualifications necessary to contribute to 

the accomplishment of the committee’s 

objectives. Nominees must meet all of 

the following mandatory qualifications 

to be eligible for consideration: 

Expertise in the field of tobacco control 

and multi-disciplinary expertise in 

public health; and knowledge of 

national health policies and programs 

managed by HHS. Additionally, 

desirable qualifications include: (1) 

Knowledge of emerging tobacco control 

policies and experience in analyzing, 

evaluating, and interpreting Federal, 

State and/or local health or regulatory 

policy that includes Point of Sale, 

warning labels, and advertising 

restrictions; or (2) knowledge of product 

regulation and the emerging 

environment of tobacco control and 

expertise in developing or contributing 

to the development of policies/or 

programs; or (3) familiarity of rapid and 

emerging surveillance systems that will 

allow for the timely evaluation of 

tobacco product regulation and/or the 

impact of tobacco control interventions. 

Balanced membership will depend 

upon several factors, including: (1) The 

committee’s mission; (2) the geographic, 

ethnic, social, economic, or scientific 

impact of the advisory committee’s 

recommendations; (3) the types of 

specific perspectives required, for 

example, such as those of consumers, 

technical experts, the public at-large, 

academia, business, or other sectors; (4) 

the need to obtain divergent points of 

view on the issues before the advisory 

committee; and (5) the relevance of 

State, local, or tribal governments to the 

development of the advisory 

committee’s recommendations. 

Members may be invited to serve for up 

to four-year terms. Nominees must be 

U.S. citizens. 

The following information must be 

submitted for each candidate: name, 

affiliation, address, telephone number, 

and current curriculum vitae. E-mail 

addresses are requested if available. 

Additionally, the following information 

must be included: (1) Letter of 

recommendation stating the nominee’s 

qualifications; (2) letter of nomination 

that provides specific attributes that 

qualify the nominee for service; (3) a 

statement indicating the nominee’s 

willingness to serve as a potential 

member of the Committee; and (4) a 

narrative addressing the nominee’s 

experience and professional/technical 

qualifications. 

Nominations should be sent 

electronically or in writing, and 

postmarked by November 19, 2010 to: 

Ms. Monica Swann, Committee 

Management Specialist, NCCDPHP, 

CDC, 4770 Buford Highway (MS–K 50), 

Chamblee, Georgia 30341. (E-mail 

address: zqe0@cdc.gov). Telephone and 

facsimile submissions cannot be 

accepted. 

Candidates invited to serve will be 

required to submit the Confidential 

Financial Disclosure Report (OGE 450) 

form for Special Government Employees 

(SGEs) serving on Federal Advisory 

Committees at CDC. This form allows 

CDC to determine whether there is a 

statutory conflict between that person’s 

public responsibilities as a SGE and 

private interests and activities, or the 

appearance of a lack of impartiality, as 

defined by Federal regulation. The form 

may be viewed and downloaded at 

http://www.usoge.gov/forms/ 

oge450_pdf/oge450_accessible.pdf. This 

form should not be submitted as part of 

a nomination. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both CDC 

and the Agency for Toxic Substances 

and Disease Registry. 


jlentini on DSKJ8SOYB1PROD with NOTICES